MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
3. Government ... Funders, Regulators, Policy Makers, Conveners
*Government: International
North America
United States of America
*Government: U.S. Federal
Organization & Developments: U.S. Federal Government
Organization & Developments: HHS
*Contractors & Awardees: FDA
Embleema
Attachments
Front Page - embleema
Parents
*Architects: Contract Research Organizations (CRO), Clinical Trials, IRB, Life Science Regulatory & Compliance Information Systems Companies
*Architects: Health IT_HIE (Health Information Exchange), Interoperability, Data Exchange, APIs (Application Programming Interfaces), Distributed Ledger Technology (DLT) & BlockChain Companies
*Contractors & Awardees: FDA
*Industry: New Jersey
Venture Capital: Series A
Children
2019: Embleema Closes $3.7M Series A Funding Round and Joins Techstars Alchemist Blockchain Accelerator Program
2019: Series A funding round, led by strategic partner Pharmagest, a leading pharmacy software group in Europe, and Techstars
Accelerating the availability of new treatments to the 350 million rare disease sufferers around the world
Embleema is creating a decentralized healthcare data economy by connecting the key stakeholders in the healthcare industry, directly with patients while maintaining the patient’s data sovereignty.
Embleema is the patient-driven healthcare blockchain network for secure sharing of personal health records.
Empowers patients to reclaim ownership of their medical data, connect directly with research studies, and be compensated for sharing their data.
Founded 2017
Hosted on a private Ethereum blockchain, Embleema’s consolidated, highly-secure repository provides the healthcare ecosystem with an undisputed and holistic view of patients’ medical history
Metuchen, New Jersey
Robert Chu, CEO and Founder, Embleema (2021)